TAK1-inhibitors did not reduce disease burden in a Vκ*MYC model of multiple myeloma

por Håland, Erling, Moen, Ingrid Nyhus, Vandsemb, Esten N., Starheim, Kristian K.
Publicado 2022

TAK1-inhibitors are cytotoxic for multiple myeloma cells alone and in combination with melphalan

por Håland, Erling, Moen, Ingrid Nyhus, Veidal, Elias, Hella, Hanne, Misund, Kristine, Slørdahl, Tobias S., Starheim, Kristian K.
Publicado 2021

Smac-mimetics reduce numbers and viability of human osteoclasts

por Moen, Ingrid Nyhus, Westhrin, Marita, Håland, Erling, Haug, Markus, Nonstad, Unni, Klaharn, Merisa, Standal, Therese, Starheim, Kristian K.
Publicado 2021